ergoline and Depressive-Disorder--Major

ergoline has been researched along with Depressive-Disorder--Major* in 5 studies

Trials

2 trial(s) available for ergoline and Depressive-Disorder--Major

Article	Year
Cerebral perfusion response to successful treatment of depression with different serotoninergic agents. The Journal of neuropsychiatry and clinical neurosciences, 2004,Summer, Volume: 16, Issue:3 In 19 patients with major depressive disorder, effective treatment with selective serotonin reuptake inhibitors (SSRIs) or amesergide (AMSG) was associated with increased cerebral perfusion in anterior cingulate cortex (SSRI and AMSG) and in medial prefrontal cortex (AMSG). Both selective serotonin reuptake inhibitors and AMSG exert antidepressant action through the serotonin (5-HT) system as reuptake inhibitors. Amesergide differs from SSRIs in that it is also a highly selective 5-HT antagonist, which may in part account for differences in cerebral blood flow response to treatment. Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Chi-Square Distribution; Depressive Disorder, Major; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon	2004
Lisurid (Lysenyl Spofa) in the treatment of organic psychosyndrome in involution. Activitas nervosa superior, 1978, Volume: 20, Issue:1 Topics: Clinical Trials as Topic; Depressive Disorder, Major; Double-Blind Method; Ergolines; Humans; Urea	1978

Article

Year

Cerebral perfusion response to successful treatment of depression with different serotoninergic agents.

The Journal of neuropsychiatry and clinical neurosciences, 2004,Summer, Volume: 16, Issue:3

In 19 patients with major depressive disorder, effective treatment with selective serotonin reuptake inhibitors (SSRIs) or amesergide (AMSG) was associated with increased cerebral perfusion in anterior cingulate cortex (SSRI and AMSG) and in medial prefrontal cortex (AMSG). Both selective serotonin reuptake inhibitors and AMSG exert antidepressant action through the serotonin (5-HT) system as reuptake inhibitors. Amesergide differs from SSRIs in that it is also a highly selective 5-HT antagonist, which may in part account for differences in cerebral blood flow response to treatment.

Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Chi-Square Distribution; Depressive Disorder, Major; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon

2004

Lisurid (Lysenyl Spofa) in the treatment of organic psychosyndrome in involution.

Activitas nervosa superior, 1978, Volume: 20, Issue:1

Topics: Clinical Trials as Topic; Depressive Disorder, Major; Double-Blind Method; Ergolines; Humans; Urea

1978

Other Studies

3 other study(ies) available for ergoline and Depressive-Disorder--Major

Article	Year
Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment. The journal of ECT, 2015, Volume: 31, Issue:2 Topics: Antidepressive Agents; Antineoplastic Agents; Cabergoline; Depressive Disorder, Major; Electroconvulsive Therapy; Ergolines; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	2015
Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Antidepressive Agents; Antineoplastic Agents; Cabergoline; Citalopram; Delusions; Depressive Disorder, Major; Ergolines; Female; Gambling; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma	2007
Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants. Pharmacopsychiatry, 2006, Volume: 39, Issue:3 Recently, tricyclic antidepressants (TCAs) have been used mainly for treatment-resistant depression (TRD) because of their significant side effects . We report a patient whose prolonged depressive symptoms dramatically improved after the cessation of TCAs. TCAs may cause deterioration of depressive symptoms due to their neurotoxicity. Topics: Adult; Antidepressive Agents, Tricyclic; Cabergoline; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Fluvoxamine; Humans; Imipramine; Substance Withdrawal Syndrome; Treatment Outcome	2006